What Happened?
Palo Alto, CA-based Forty-Seven Appointed Mark McCamish as President and Chief Executive Officer
About the Company
With a passion for pioneering breakthrough solutions, we are committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity.
About the Person
Mark McCamish is President and Chief Executive Officer at Forty Seven. Previously, Mark held various senior HR leadership roles in the industry.
Info Source
News
Short Profile